Related Experiment Videos

Sphingomyelinase activity of Staphylococcus aureus strains from recurrent furunculosis and other infections

Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology
|June 1, 1982
PubMed

Insights

Staphylococcus aureus strains producing sphingomyelinase (beta-hemolysin) were studied. High enzyme production correlated with recurrent furunculosis and more severe skin lesions, suggesting a role in disease severity.

Area of Science:

  • Microbiology
  • Enzymology
  • Dermatology

Background:

  • Staphylococcus aureus is a common pathogen.
  • Sphingomyelinase (beta-hemolysin) is a virulence factor.
  • Its role in skin infections requires further investigation.

Purpose of the Study:

  • To quantify sphingomyelinase production in Staphylococcus aureus strains.
  • To correlate enzyme production with clinical isolates and phage types.
  • To investigate the relationship between sphingomyelinase and skin lesion severity.

Main Methods:

  • Enzyme impression test (EIT) for qualitative assessment.
  • Enzyme assay test (EAT) using 14C-sphingomyelin for quantitative assessment.
  • Analysis of 180 Staphylococcus aureus strains from various clinical sources and healthy carriers.

Main Results:

  • 33% of strains were positive for enzyme production in EIT.
  • Highest frequency of enzyme production observed in strains from recurrent furunculosis (45%).
  • High sphingomyelinase producers were associated with furunculosis strains, phage types 55/71, and caused more intense skin lesions.

Conclusions:

  • Sphingomyelinase production varies among Staphylococcus aureus strains.
  • High sphingomyelinase production is linked to recurrent furunculosis and increased lesion severity.
  • This enzyme may be a significant factor in Staphylococcus aureus-related skin pathology.

Related Concept Videos